SRI InternationalJul 2 2024 Research ers in SRI's Pharmaceutical Sciences Lab are working on an affordable, shelf-stable anti-malarial drug formulation that could provide months of protection against the mosquito-borne disease with just a single injection, which means that individuals would no longer have to worry about missing a dose. Additionally, it has a low propensity for resistance and can be effective where drug resistance exists.
In a paper published in the European Journal of Pharmaceutical Sciences, Shankar and her colleagues demonstrated that their novel injectable formulation could slowly release the anti-malarial drug ELQ-331 into the bloodstream. The formulation maintained high enough concentrations of the drug to act as a long-term preventative against malaria parasites.
Related Stories"It was basically impossible to administer and sustain its effectiveness for a long period," Shankar said. "My group's expertise is in targeting drugs efficiently. We developed a formulation that allowed this challenging molecule to be given in an injectable form and to be available in circulation for a sustained period.
Source: Healthcare Press (healthcarepress.net)
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sri Lanka closes schools as floods and mudslides leave trail of dead and missingHeavy rain triggered floods and mudslides in many parts of the island nation.
Source: Observer_Owl - 🏆 18. / 72 Read more »
Sri Lanka closes schools as floods and mudslides leave trail of dead and missingHeavy rain triggered floods and mudslides in many parts of the island nation.
Source: Glasgow_Times - 🏆 76. / 59 Read more »
Source: BBCSport - 🏆 111. / 51 Read more »
Source: BBCSport - 🏆 111. / 51 Read more »
Source: SkySports - 🏆 58. / 63 Read more »
Source: SkySports - 🏆 58. / 63 Read more »